The Quality Lowdown: ICH Q9, FDA QMM, THC Impurities And Recertified MAPPs
Executive Summary
Alphabet soup of policy developments includes an answer to subjectivity in risk assessment, the unexpected industry benefit of the FDA’s quality rating plans, and some advice on testing for impurities that could be controlled substances.
You may also be interested in...
Quality Management Maturity Scheme Questioned As US FDA Seeks Testers For Next Phase
Agency asks manufacturing facilities to volunteer for prototype quality management maturity assessment protocol, while industry questions overall direction of QMM program and points to emergence of better ways to predict quality and reliability.
What Carrots Will US FDA Offer For Quality Management Maturity Participation?
Sector-specific incentives may be necessary, but the FDA has not made a final decision.
US FDA Makes Case For Quality Management Maturity Ratings
High ratings could strengthen company financial performance, agency suggests. But stakeholders would need to understand the difference between site QMM and product quality for the incentives to work properly. More details to follow in upcoming workshop.